CD4+CD25+ T regulatory cells (Tregs) prevent autoimmune disease, yet little is known about precisely where they exert their influence naturally in a spontaneous autoimmune disorder. Here, we report that Tregs and T effector cells (Teffs) coexist within the pancreatic lesion before type 1 diabetes onset. We find that BDC2.5 T cell receptor transgenic animals contain a small subset of FoxP3 positive CD4+CD25+CD69− cells in the pancreas, actively turning over, expressing the clonotypic receptor, and containing functional regulatory activity. Gene expression profiling confirms that the CD4+CD25+CD69− cells in pancreatic tissue express transcripts diagnostic of regulatory cells, but with significantly higher levels of interleukin 10 and inducible costimulator (ICOS) than their lymph node counterparts. Blockade of ICOS rapidly converts early insulitis to diabetes, which disrupts the balance of Teffs and Tregs and promotes a very broad shift in the expression of the T regulatory–specific profile. Thus, CD4+CD25+69− Tregs operate directly in the autoimmune lesion and are dependent on ICOS to keep it in a nondestructive state.
Skip Nav Destination
Article navigation
7 June 2004
Article|
June 07 2004
CD4+CD25+ T Regulatory Cells Dependent on ICOS Promote Regulation of Effector Cells in the Prediabetic Lesion
Ann E. Herman,
Ann E. Herman
1Section on Immunology and Immunogenetics, Joslin Diabetes Center
Search for other works by this author on:
Gordon J. Freeman,
Gordon J. Freeman
3Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215
Search for other works by this author on:
Diane Mathis,
Diane Mathis
1Section on Immunology and Immunogenetics, Joslin Diabetes Center
2Department of Medicine, Brigham and Women's Hospital,
Search for other works by this author on:
Christophe Benoist
Christophe Benoist
1Section on Immunology and Immunogenetics, Joslin Diabetes Center
2Department of Medicine, Brigham and Women's Hospital,
Search for other works by this author on:
Ann E. Herman
1Section on Immunology and Immunogenetics, Joslin Diabetes Center
Gordon J. Freeman
3Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215
Diane Mathis
1Section on Immunology and Immunogenetics, Joslin Diabetes Center
2Department of Medicine, Brigham and Women's Hospital,
Christophe Benoist
1Section on Immunology and Immunogenetics, Joslin Diabetes Center
2Department of Medicine, Brigham and Women's Hospital,
Address correspondence to Diane Mathis, Section on Immunology and Immunogenetics, Joslin Diabetes Center and Dept. of Medicine, Brigham and Women's Hospital, Harvard Medical School, One Joslin Pl., Research 4th Fl., Boston, MA 02215. Phone: (617) 264-2743; Fax: (617) 264-2744; email: [email protected]; or Christophe Benoist. Phone: (617) 264-2742; Fax: (617) 264-2744; email: [email protected]
The online version of this article contains supplemental material.
Abbreviations used in this paper: FPR, false positive rate; ICOS, inducible costimulator; ILN, inguinal LN; MLN, mesenteric LN; PLN, pancreatic LN; Teff, T effector cell; Treg, T regulatory cell.
Received:
January 28 2004
Accepted:
May 05 2004
Online ISSN: 1540-9538
Print ISSN: 0022-1007
The Rockefeller University Press
2004
J Exp Med (2004) 199 (11): 1479–1489.
Article history
Received:
January 28 2004
Accepted:
May 05 2004
Citation
Ann E. Herman, Gordon J. Freeman, Diane Mathis, Christophe Benoist; CD4+CD25+ T Regulatory Cells Dependent on ICOS Promote Regulation of Effector Cells in the Prediabetic Lesion . J Exp Med 7 June 2004; 199 (11): 1479–1489. doi: https://doi.org/10.1084/jem.20040179
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement